87 related articles for article (PubMed ID: 2184428)
1. [Immunohistochemical detection of progesterone receptors in breast cancer. Comparison of antibodies mPRI and PR-ICA].
Weikel W; Rosenthal H; Beck T; Mitze M
Pathologe; 1990 Mar; 11(2):85-8. PubMed ID: 2184428
[No Abstract] [Full Text] [Related]
2. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
Ronay G; Sponsel N; Merkle E; Tulusan AH
Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
[No Abstract] [Full Text] [Related]
3. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
Scharl A; Vierbuchen M; Würz H
Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630
[No Abstract] [Full Text] [Related]
4. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections].
Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J
Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912
[No Abstract] [Full Text] [Related]
5. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
Ronay G; Sponsel N; Tulusan AH
Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
[No Abstract] [Full Text] [Related]
6. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases].
Fleige B; Pickartz H; Stein H
Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629
[No Abstract] [Full Text] [Related]
7. [Comparison of binding patterns of established and new monoclonal antibodies, of antisera and lectins with impulse cytophotometric and morphometric parameters and the hormone receptor status of breast cancer].
Möller P; Gross C; Feichter G; Mattfeldt T; Kaufmann M
Verh Dtsch Ges Pathol; 1985; 69():405-8. PubMed ID: 3913203
[No Abstract] [Full Text] [Related]
8. [Initial experiences with a monoclonal antibody to the progesterone receptor complex].
Neis KJ; Macher F; Kaul S; Bastert G
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():109-14. PubMed ID: 2703136
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
Prechtel D; Prechtel K
Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
[No Abstract] [Full Text] [Related]
10. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
11. [Cell receptors and proliferation markers in breast cancer].
Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
[No Abstract] [Full Text] [Related]
12. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
[TBL] [Abstract][Full Text] [Related]
15. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
von Minckwitz G; Kaufmann M
Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
[No Abstract] [Full Text] [Related]
16. Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.
Charpin C; Jacquemier J; Andrac L; Vacheret H; Habib MC; Devictor B; Lavaut MN; Toga M
Am J Pathol; 1988 Aug; 132(2):199-211. PubMed ID: 2456699
[TBL] [Abstract][Full Text] [Related]
17. [Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].
Nizze H; al-Thobhani AK; Terpe H
Zentralbl Chir; 1998; 123 Suppl 5():14-8. PubMed ID: 10063564
[TBL] [Abstract][Full Text] [Related]
18. [The ER-ICA, Lee and Taylor technics in breast carcinoma].
Gambacorta M; Gianni MT
Pathologica; 1987; 79(1059-1060):119-24. PubMed ID: 3327039
[No Abstract] [Full Text] [Related]
19. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
Pickartz H
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
[No Abstract] [Full Text] [Related]
20. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
